Jeffrey Aronoff, MD
Colon & Rectal Surgery · New York, NYNPI 1699869883
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,067 of the $4,047 with a category attached, or 75.8%. It is spread thinly across 34 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,084 and has fallen 68.5% since, to $342 in 2025.
Across 182 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$698
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$496
- AbbVie$381
- Medical Device Business Services, Inc.$305
- QOL Medical, LLC$301
- Baxter Healthcare$243
- plus $2K from 28 others
What the payments were for
- Consulting fees$67517%
- Food & beverage$3,06776%
- Education$3058%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 2 | $698 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 50 | $496 |
| AbbVie | 28 | $381 |
| Medical Device Business Services, Inc. | 1 | $305 |
| QOL Medical, LLC | 20 | $301 |
| Baxter Healthcare | 2 | $243 |
| Braintree Laboratories, Inc. | 9 | $239 |
| Medtronic(2 entities) | 11 | $235 |
| Axonics, Inc. | 7 | $186 |
| Johnson & Johnson(2 entities) | 8 | $153 |
| Ardelyx, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Celltrion USA Inc. | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 3 | $56 |
| Redhill Biopharma Inc. | 3 | $51 |
| Novum Pharma, LLC | 3 | $50 |
| Ironwood Pharmaceuticals, Inc | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $30 |
| Integra Lifesciences Corporation | 1 | $29 |
| Acell, Inc. | 1 | $28 |
| Myriad Genetic Laboratories, Inc. | 1 | $26 |
| GSK | 2 | $25 |
| Shire North American Group Inc | 1 | $25 |
| Evoke Pharma, Inc. | 1 | $23 |
| VBI Vaccine (delaware) Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Trevena, Inc. | 1 | $18 |
| Olympus America Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Romark Laboratories, LC | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,047 in reported general payments places this provider in the 65th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 80 | $4,899 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $368 |
| Lidocaine | 14 | $289 |
| Metoclopramide Hcl | 85 | $128 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $87 |
| Metronidazole | 19 | $40 |
| Ciprofloxacin Hcl | 13 | $19 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in New York
- Sanghyun KimNew York$154K
- Mehraneh JafariNew York$50K
- Jeffrey MilsomNew York$42K
- David SchwartzbergNew York$26K
- Richard WhelanNew York$23K
- Alessandro FicheraNew York$20K
- Juliet RayNew York$17K
- Cary AaronsNew York$16K
- Debbie BakesNew York$15K
- Parul ShuklaNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.